Stock VERV VERVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Verve Therapeutics, Inc.

Equities

VERV

US92539P1012

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-14 EDT 		5-day change 1st Jan Change
5.42 USD -3.21% Intraday chart for Verve Therapeutics, Inc. +4.03% -61.12%
06-10 Transcript : Verve Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM
05-31 Verve Therapeutics Names Troy Lister Chief Scientific Officer MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
VERVE THERAPEUTICS, INC.
Other Biotechnology & Medical Research
-3.21%+4.03%-61.12%-72.68% - 455M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. VERV Stock
  4. Charts Verve Therapeutics, Inc.
  5. Comparison Chart